terazosin has been researched along with atrial natriuretic factor in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Toni, R; Fazari, G; Fontebasso, A; Gebbin, A; Pessina, AC; Semplicini, A; Serena, L; Valle, R | 1 |
De Toni, R; Fontebasso, A; Gebbin, A; Gerardi, G; Pessina, AC; Semplicini, A; Serena, L; Valle, R | 1 |
Bishopric, NH; Pratt, RE; Wu, CF | 1 |
1 trial(s) available for terazosin and atrial natriuretic factor
Article | Year |
---|---|
[Pressure and metabolic effects of terazosin in essential hypertension].
Topics: Adrenergic alpha-Antagonists; Adult; Atrial Natriuretic Factor; Blood Glucose; Double-Blind Method; Female; Humans; Hypertension; Insulin Resistance; Lipids; Male; Middle Aged; Prazosin | 1994 |
2 other study(ies) available for terazosin and atrial natriuretic factor
Article | Year |
---|---|
Long-term alpha-1 adrenoceptor blockade does not affect plasma atrial natriuretic peptide in hypertensive patients.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Prazosin | 1994 |
Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adrenergic alpha-Antagonists; Animals; Animals, Newborn; Apoptosis; Atrial Natriuretic Factor; Cell Nucleus; Cells, Cultured; Cyclic GMP; Desmin; DNA Fragmentation; Dose-Response Relationship, Drug; Heart; Kinetics; Myeloid Cell Leukemia Sequence 1 Protein; Myocardium; Neoplasm Proteins; Nitroprusside; Norepinephrine; Phosphodiesterase Inhibitors; Polymerase Chain Reaction; Prazosin; Propranolol; Proto-Oncogene Proteins c-bcl-2; Purinones; Rats; Receptors, Atrial Natriuretic Factor | 1997 |